[Effects of pretreatment with recombinant human B-type natriuretic peptide on infarct size in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].

Shiqiang Li, Xianghua Fu, Yuhan Dai, Chen Liu, Yanbo Wang, Wei Li, Weili Wu, Xinshun Gu, Guozhen Hao, Weize Fan, Qing Miao, Yunfa JiangPubMed 2015

Abstract

Administration of rhBNP before PCI with post-conditioning procedure can further improve myocardial perfusion, limit myocardial infarct size, ameliorate cardiac dysfunction and postpone left ventricular early-stage and long-term remodeling in STEMI patients undergoing primary PCI.
BibTeX
@inproceedings{li2015effects,
  author = {Shiqiang Li and Xianghua Fu and Yuhan Dai and Chen Liu and Yanbo Wang and Wei Li and Weili Wu and Xinshun Gu and Guozhen Hao and Weize Fan and Qing Miao and Yunfa Jiang},
  title = {{[Effects of pretreatment with recombinant human B-type natriuretic peptide on infarct size in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].}},
  booktitle = {PubMed},
  year = {2015},
}

Loading related content...

Figure